GlobeNews Wire

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing…

2 months ago

AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients

AURORA, COLORADO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

2 months ago

“Best Peptides for Hair Growth” Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026

Vero Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…

2 months ago

Alchera X Advances Industry Leadership with Executive Feature in Leading Technology Publication during CES 2026 in Las Vegas

LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alchera X (AX), a global leader in AI-powered facial recognition and computer…

2 months ago

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.

January 08, 2026 18:13 ET  | Source: Semilux International Ltd. Taipei, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Semilux International…

2 months ago

Lafayette Digital Acquisition Corp. I Announces Pricing of $250,000,000 Initial Public Offering

January 08, 2026 18:10 ET  | Source: Lafayette Digital Acquisition Corp. I Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) --…

2 months ago

Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics

Leuven, Belgium. January 8, 2026. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated to transforming patients’ lives with…

2 months ago

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis

Company has built one of the largest proprietary extracellular matrix (ECM) datasets spanning fibrosis and solid tumors January 08, 2026…

2 months ago

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

January 08, 2026 03:00 ET  | Source: PathAI BOSTON, Mass. and ZURICH, Switzerland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PathAI,…

2 months ago

illumin Announces CFO Transition

January 07, 2026 19:02 ET  | Source: illumin TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM)…

2 months ago